본문영역 바로가기
ABL Bio - medicine for A Better Life
About Us
Who We Are
History
Corporate Identity
Leadership
Contact Us
ESG
Platform & Strategies
Platform
Oncology Strategy
CNS Disease Strategy
ADC Strategy
Publications
Pipeline
Overview
ABL301
ABL503
ABL111
ABL102
ABL103
ABL104
ABL105
Investors & Media
Public Disclosure
Stock Information
Finance Information
Notice
News
Document & Materials
Careers
KOR
ENG
모바일 메뉴 보기
Investors & Media
Document & Materials
Home
Investors & Media
Document & Materials
에이비엘바이오 IR자료 (2022년 4월)
2022-04-18
ablbio
IR자료
ABLbio_IR Material_2022APR(KOR)_2022-04-18.pdf
2022.04.18 기준
list
PREV
[BIO NEWS] SPECIAL TALK with AblBio CEO Lee Sang Hoon
NEXT
Grabody™-T and Grabody™-I : ABL Bio's Immuno-Oncology Platform
ABL Bio
About Us
Who We Are
History
Corporate Identity
Leadership
Contact Us
ESG
Platform & Strategies
Platform
Oncology Strategy
CNS Disease Strategy
ADC Strategy
Publications
Pipeline
Overview
ABL301
ABL503
ABL111
ABL102
ABL103
ABL104
ABL105
Investors & Media
Public Disclosure
Stock Information
Finance Information
Notice
News
Document & Materials
Careers
Core Competencies
Benefits
Recruitment
Recruiting Process
메뉴닫기